Similar articles

• Cardiogenic shock. Recent advances in pharmacologic management. II.

  Kones RJ. Kones RJ. N Y State J Med. 1973 Aug 1;73(15):1967-80. N Y State J Med. 1973. PMID: 4354585 Review. No abstract available.
• [Endogenous estecholamines in regional myocardial hypoxia and ways of inhibiting their cardiotoxic effect (review of the literature)].

  Gatsura VV. Gatsura VV. Farmakol Toksikol. 1977 Jan-Feb;40(1):105-13. Farmakol Toksikol. 1977. PMID: 192581 Review. Russian. No abstract available.
• [Catecholamines for treatment of severe heart failure (author's transl)].

  Mäurer W, Tillmanns H, Kübler W. Mäurer W, et al. Z Kardiol. 1979 May;68(5):290-7. Z Kardiol. 1979. PMID: 223342 German.
• Sulfonylureas and the heart.

  Levey GS, Lasseter KC, Palmer RF. Levey GS, et al. Annu Rev Med. 1974;25:69-74. doi: 10.1146/annurev.me.25.020174.000441. Annu Rev Med. 1974. PMID: 4363211 Review. No abstract available.
• Use of catecholamines in acute myocardial infarction.

  Dixon DW, Loeb HS, Gunnar RM. Dixon DW, et al. Herz. 1979 Oct;4(5):385-96. Herz. 1979. PMID: 391685 Review.